Drug Discovery and Development, July 3, 2007 GALVESTON -- A research team reports that a Listeria protein called InlB induces internalization and degradation of a human receptor known as Met, implicated in the development of some cancers. They found that the ability of InlB to induce Met internalization and degradation requires a human protein called Cbl. If scientists could figure out how to control Cbl, such knowledge might lead to the development of drugs that induce the destruction of Met and are useful in treating Met-related cancers. The research, conducted by the University of Texas Medical Branch and the University of Central Florida was published in this month's issue of the journal Cellular Microbiology.